Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies
Abstract Background The blood-brain barrier (BBB) presents a formidable challenge in neuropharmacology, limiting the delivery of therapeutic agents to the brain. Exosomes, nature’s nanocarriers, have emerged as a promising solution due to their biocompatibility, low immunogenicity, and innate abilit...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2025-05-01
|
| Rangatū: | Journal of Nanobiotechnology |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s12951-025-03352-8 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|